WO2001053539A1 - Sensitive, multiplexed diagnostic assays for protein analysis - Google Patents
Sensitive, multiplexed diagnostic assays for protein analysisInfo
- Publication number
- WO2001053539A1 WO2001053539A1 PCT/US2001/000291 US0100291W WO0153539A1 WO 2001053539 A1 WO2001053539 A1 WO 2001053539A1 US 0100291 W US0100291 W US 0100291W WO 0153539 A1 WO0153539 A1 WO 0153539A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- protein
- kit
- compound
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
Definitions
- the invention relates to diagnostic methods involving multiplex analysis.
- a variety of methods exist to detect multiple species in a biological sample include ELISA based immunoabsorbent assays, protein biochips, and the like. Each of these methods suffers from limitations in detection sensitivity or selectivity, due, for example, to kinetics of binding or sensitivity of detection reagents. In addition, these techniques are also limited in terms of the number of molecules that can be rapidly detected.
- the present invention involves a novel multiplex diagnostic approach for the ultra-sensitive detection of molecules in biological samples.
- binding reagents typically protein binding reagents.
- Each of these reagents binds to a different target in a sample, facilitating the detection of several targets simultaneously.
- the targets of the binding reagents are frequently proteins, but they may be any moiety capable of specific binding, including, for example, nucleic acids or sugar moieties.
- binding reagents may represent naturally-occurring or partially or completely synthetic amino acid sequences.
- binding reagents include, without limitation, members of the following binding pairs: antigen/antibody pairs, protein/inhibitor pairs, receptor/ligand pairs (for example cell surface receptor/ligand pairs, such as hormone receptor/peptide hormone pairs), enzyme/substrate pairs (for example, kinase/substrate pairs), lectin/carbohydrate pairs, oligomeric or heterooligomeric protein aggregates, DNA binding protein/DNA binding site pairs, RNA/protein pairs, and nucleic acid duplexes, heteroduplexes, or ligated strands, as well as any molecule which is capable of forming one or more covalent or non-covalent bonds (for example, disulfide bonds) with any portion of a nucleic acid-protein fusion.
- binding reagents may be derived by any technique, for example, by directed evolution approaches using a desired protein as the binding target.
- binding reagents are utilized in a single diagnostic reaction mixture, they are preferably similar in composition and amino acid length.
- a common amino acid scaffold or structural motif that displays the binding domain on one face of the molecule, as is the case for an antibody scaffold that displays CDR regions as a binding region of the molecule.
- a particularly useful binding scaffold is the 10 th domain of type III fibronectin (see, for example, Lipovsek et al., Protein Scaffolds for Antibody Mimics and Other Binding Proteins, U.S.S.N. 09/456,693; U.S.S.N. 09/515,260; U.S.S.N. 09/688,566; WO 00/34784).
- the compound to be detected by the present approach may be any substance to which a protein may bind, and is preferably itself a protein.
- target compounds may be present in any sample, for example, any biological sample.
- Typical biological samples include, without limitation, any fluid or tissue derived from an organism, for example, a plant or a mammal such as a human.
- each of the binding domains is covalently attached to a nucleic acid that encodes the binding domain.
- nucleic acid-protein fusion molecules can be produced by any method, for example, by the method of Roberts and Szostak (Szostak et al., U.S.S.N. 09/007,005 and U.S.S.N.
- peptide acceptor any molecule capable of being added to the C-terminus of a growing protein chain by the catalytic activity of the ribosomal peptidyl transferase function.
- such molecules contain (i) a nucleotide or nucleotide-like moiety (for example, adenosine or an adenosine analog (di-methylation at the N-6 amino position is acceptable)), (ii) an amino acid or amino acid-like moiety (for example, any of the 20 D- or L-amino acids or any amino acid analog thereof (for example, O-methyl tyrosine or any of the analogs described by Ellman et al., Meth. Enzymol.
- a nucleotide or nucleotide-like moiety for example, adenosine or an adenosine analog (di-methylation at the N-6 amino position is acceptable
- an amino acid or amino acid-like moiety for example, any of the 20 D- or L-amino acids or any amino acid analog thereof (for example, O-methyl tyrosine or any of the analogs described by Ellman et al., Meth. Enzymol.
- Peptide acceptors may also possess a nucleophile, which may be, without limitation, an amino group, a hydroxyl group, or a sulfhydryl group.
- peptide acceptors may be composed of nucleotide mimetics, amino acid mimetics, or mimetics of the combined nucleotide-amino acid structure.
- any other unique, PCR-amplifiable nucleic acid for example, RNA, DNA, PNA, or any other nucleic acid which includes two or more covalently bonded, naturally- occurring or modified ribonucleotides or deoxyribonucleotides
- the protein portions of the fusions are typically, composed of naturally-occurring amino acid residues, but may also include amino acid analogs or derivatives, joined by peptide or peptoid bond(s).
- each binding domain is associated with (and can therefore be identified by) a unique, amplifiable nucleic acid tag, and that each tag in a multiplex reaction is of identical (or essentially identical) length to avoid amplification (for example, PCR) biases.
- unique identification tags are nucleic acid sequences that differ sufficiently in sequence from other tags in a given population or reaction mixture that significant cross-hybridization does not occur under the conditions employed.
- These unique identification tags may be present in the protein encoding portion of the fusion (for example, the tag can be a randomized portion of the protein scaffold, such as a randomized loop of the 10 th domain of fibronectin type III).
- the unique identification tag can be added to the nucleic acid portion of the fusion molecule and be positioned outside of the nucleic acid sequence which encodes the compound binding domain or, if present, its associated scaffold region.
- unique identification tags may be chosen which most effectively, most selectively, or most conveniently identify the fusion molecule. For example, if binding reagents are deconvoluted on a DNA chip, tag(s) may be chosen which best hybridize to immobilized chip nucleic acid(s) or which are compatible with commercially available chip arrays.
- DNA chips represent a preferred solid support according to the invention
- deconvolution may also be carried out on other solid substrates including, without limitation, any other type of chip (for example, silica-based, glass, or gold chip), glass slide, membrane, bead, solid particle (for example, agarose, sepharose, or magnetic bead), column (or column material), membrane (for example, the membrane of a liposome or vesicle), test tube, or microtiter dish.
- chip for example, silica-based, glass, or gold chip
- glass slide membrane
- bead solid particle
- solid particle for example, agarose, sepharose, or magnetic bead
- column or column material
- membrane for example, the membrane of a liposome or vesicle
- test tube or microtiter dish.
- the present method may be carried out, in one preferred embodiment, as follows.
- the high affinity binding reagents each containing a unique affinity binding domain and being present in a mixture of anywhere from 1 to 500,000 (each with equilibrium constants of less than 500 nM), are combined with a sample (for example, a biological sample), under conditions which allow each affinity binding domain to reproducibly recognize a binding partner(s).
- a sample for example, a biological sample
- the complex is captured. This can be accomplished through any standard procedure, for example, by biotinylation of the biological sample, followed by capture of biotinylated complexes using immobilized streptavidin (for example, streptavidin immobilized on magnetic beads or a column).
- the initial protein sample may be preabsorbed onto a membrane and the binding domains mixed with the membrane. Complexes remain bound, while unbound binding reagents are washed away.
- binding domains that have bound their target(s) in the biological sample are detected simply by performing a PCR reaction using primers which hybridize to the nucleic acid portion of the fusion molecule.
- the PCR reaction is carried out using standard quantitative methods (for example, using Taq Man by Perkin- Elmer).
- the isolated pool is then deconvoluted and individual members identified.
- the identification step may be accomplished through direct sequencing.
- the isolated pool is deconvoluted and bound analytes identified using DNA chip array detection.
- the PCR reaction is stopped following predefined cycles, and aliquots extracted. In this way, DNA array detection is performed on each aliquot, allowing for quantitative analysis of amounts of each species present in the pool.
- a critical feature of the PCR step is that the unique identifiable tag is amplified, and that each amplified segment is the result of using identical primers that generate a DNA product of identical (or essentially identical) size.
- kits for carrying out any of the methods described herein include at least three important components: (a) a nucleic acid-protein fusion having a protein portion that specifically binds to a desired compound and a nucleic acid portion that both encodes the protein portion and includes a unique identification tag; (b) a PCR primer pair, in which the first primer is designed to hybridize to the nucleic acid portion of the fusion 5' to the unique identification tag and the second primer is designed to hybridize to the nucleic acid portion of the fusion 3' to the unique identification tag and in which hybridization of the primers to the fusion permits amplification of the unique identification tag; and (c) a solid support that includes a nucleic acid that can hybridize to the unique identification tag
- the kits of the invention may include any of the preferred components discussed above with respect to the preferred methods of the invention.
- the reagents of the present invention have a multitude of uses in the diagnostic industry and may be substituted for monoclonal antibodies in any use or method for which such antibodies are employed.
- the molecules described herein may be used for deconvoluting species in complex biological samples.
- the present approach offers a fast, simple way for detecting species using PCR, a detection technique that is virtually unparalleled in its sensitivity. Coupled with the unique advances for PCR in quantitation of individual species and in DNA array platforms for deconvoluting and detecting low levels of species, the present invention represents the state of the art in the diagnostic area.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001553398A JP2003520050A (en) | 2000-01-24 | 2001-01-04 | Sensitive multiplexed diagnostic assays for protein analysis |
CA002396810A CA2396810A1 (en) | 2000-01-24 | 2001-01-04 | Sensitive, multiplexed diagnostic assays for protein analysis |
AU29279/01A AU783689B2 (en) | 2000-01-24 | 2001-01-04 | Sensitive, multiplexed diagnostic assays for protein analysis |
DE60118527T DE60118527D1 (en) | 2000-01-24 | 2001-01-04 | SENSITIVE AND MULTIPLEXED DIAGNOSTIC TESTS FOR PROTEIN ANALYSIS |
EP01942678A EP1250463B1 (en) | 2000-01-24 | 2001-01-04 | Sensitive, multiplexed diagnostic assays for protein analysis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17787300P | 2000-01-24 | 2000-01-24 | |
US60/177,873 | 2000-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001053539A1 true WO2001053539A1 (en) | 2001-07-26 |
Family
ID=22650272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/000291 WO2001053539A1 (en) | 2000-01-24 | 2001-01-04 | Sensitive, multiplexed diagnostic assays for protein analysis |
Country Status (8)
Country | Link |
---|---|
US (1) | US6489116B2 (en) |
EP (1) | EP1250463B1 (en) |
JP (1) | JP2003520050A (en) |
AT (1) | ATE322558T1 (en) |
AU (1) | AU783689B2 (en) |
CA (1) | CA2396810A1 (en) |
DE (1) | DE60118527D1 (en) |
WO (1) | WO2001053539A1 (en) |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10145226A1 (en) * | 2001-09-13 | 2003-04-10 | Lifebits Ag | Manufacture of carrier-bound molecules |
EP1377828A2 (en) * | 2001-04-10 | 2004-01-07 | Children's Medical Center Corporation | Methods of analysis and labeling of protein-protein interactions |
EP1419274A1 (en) * | 2001-07-31 | 2004-05-19 | Phylos, Inc. | Modular assembly of nucleic acid-protein fusion multimers |
WO2005026387A1 (en) * | 2003-09-18 | 2005-03-24 | Nuevolution A/S | A method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
US8932992B2 (en) | 2001-06-20 | 2015-01-13 | Nuevolution A/S | Templated molecules and methods for using such molecules |
US9096951B2 (en) | 2003-02-21 | 2015-08-04 | Nuevolution A/S | Method for producing second-generation library |
US9109248B2 (en) | 2002-10-30 | 2015-08-18 | Nuevolution A/S | Method for the synthesis of a bifunctional complex |
US9121110B2 (en) | 2002-12-19 | 2015-09-01 | Nuevolution A/S | Quasirandom structure and function guided synthesis methods |
US9574189B2 (en) | 2005-12-01 | 2017-02-21 | Nuevolution A/S | Enzymatic encoding methods for efficient synthesis of large libraries |
US10640763B2 (en) | 2016-05-31 | 2020-05-05 | Cellular Research, Inc. | Molecular indexing of internal sequences |
US10669570B2 (en) | 2017-06-05 | 2020-06-02 | Becton, Dickinson And Company | Sample indexing for single cells |
US10730906B2 (en) | 2002-08-01 | 2020-08-04 | Nuevolutions A/S | Multi-step synthesis of templated molecules |
US10731151B2 (en) | 2002-03-15 | 2020-08-04 | Nuevolution A/S | Method for synthesising templated molecules |
US10927419B2 (en) | 2013-08-28 | 2021-02-23 | Becton, Dickinson And Company | Massively parallel single cell analysis |
US10941396B2 (en) | 2012-02-27 | 2021-03-09 | Becton, Dickinson And Company | Compositions and kits for molecular counting |
US11225655B2 (en) | 2010-04-16 | 2022-01-18 | Nuevolution A/S | Bi-functional complexes and methods for making and using such complexes |
USRE48913E1 (en) | 2015-02-27 | 2022-02-01 | Becton, Dickinson And Company | Spatially addressable molecular barcoding |
US11319583B2 (en) | 2017-02-01 | 2022-05-03 | Becton, Dickinson And Company | Selective amplification using blocking oligonucleotides |
US11332776B2 (en) | 2015-09-11 | 2022-05-17 | Becton, Dickinson And Company | Methods and compositions for library normalization |
US11365409B2 (en) | 2018-05-03 | 2022-06-21 | Becton, Dickinson And Company | Molecular barcoding on opposite transcript ends |
US11390914B2 (en) | 2015-04-23 | 2022-07-19 | Becton, Dickinson And Company | Methods and compositions for whole transcriptome amplification |
US11460468B2 (en) | 2016-09-26 | 2022-10-04 | Becton, Dickinson And Company | Measurement of protein expression using reagents with barcoded oligonucleotide sequences |
US11492660B2 (en) | 2018-12-13 | 2022-11-08 | Becton, Dickinson And Company | Selective extension in single cell whole transcriptome analysis |
US11525157B2 (en) | 2016-05-31 | 2022-12-13 | Becton, Dickinson And Company | Error correction in amplification of samples |
US11535882B2 (en) | 2015-03-30 | 2022-12-27 | Becton, Dickinson And Company | Methods and compositions for combinatorial barcoding |
US11639517B2 (en) | 2018-10-01 | 2023-05-02 | Becton, Dickinson And Company | Determining 5′ transcript sequences |
US11649497B2 (en) | 2020-01-13 | 2023-05-16 | Becton, Dickinson And Company | Methods and compositions for quantitation of proteins and RNA |
US11661631B2 (en) | 2019-01-23 | 2023-05-30 | Becton, Dickinson And Company | Oligonucleotides associated with antibodies |
US11661625B2 (en) | 2020-05-14 | 2023-05-30 | Becton, Dickinson And Company | Primers for immune repertoire profiling |
US11739443B2 (en) | 2020-11-20 | 2023-08-29 | Becton, Dickinson And Company | Profiling of highly expressed and lowly expressed proteins |
US11773441B2 (en) | 2018-05-03 | 2023-10-03 | Becton, Dickinson And Company | High throughput multiomics sample analysis |
US11773436B2 (en) | 2019-11-08 | 2023-10-03 | Becton, Dickinson And Company | Using random priming to obtain full-length V(D)J information for immune repertoire sequencing |
US11845986B2 (en) | 2016-05-25 | 2023-12-19 | Becton, Dickinson And Company | Normalization of nucleic acid libraries |
US11932901B2 (en) | 2020-07-13 | 2024-03-19 | Becton, Dickinson And Company | Target enrichment using nucleic acid probes for scRNAseq |
US11932849B2 (en) | 2018-11-08 | 2024-03-19 | Becton, Dickinson And Company | Whole transcriptome analysis of single cells using random priming |
US11939622B2 (en) | 2019-07-22 | 2024-03-26 | Becton, Dickinson And Company | Single cell chromatin immunoprecipitation sequencing assay |
US11965209B2 (en) | 2003-09-18 | 2024-04-23 | Nuevolution A/S | Method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7045311B2 (en) * | 2001-10-25 | 2006-05-16 | Monogram Biosciences, Inc. | Whole cell assay systems for cell surface proteases |
AU2002365404A1 (en) * | 2001-11-27 | 2003-06-10 | Compound Therapeutics, Inc. | Solid-phase immobilization of proteins and peptides |
WO2003061570A2 (en) * | 2002-01-16 | 2003-07-31 | Zyomyx, Inc. | Engineered binding proteins |
US20030166010A1 (en) * | 2002-02-25 | 2003-09-04 | Affholter Joseph A. | Custom ligand design for biomolecular filtration and purification for bioseperation |
US20030198973A1 (en) * | 2002-04-23 | 2003-10-23 | The Molecular Sciences Institute, Inc. | Chimeric fusion molecule for analyte detection and quantitation |
US20040229294A1 (en) * | 2002-05-21 | 2004-11-18 | Po-Ying Chan-Hui | ErbB surface receptor complexes as biomarkers |
US7402397B2 (en) | 2002-05-21 | 2008-07-22 | Monogram Biosciences, Inc. | Detecting and profiling molecular complexes |
WO2004094456A2 (en) | 2003-04-18 | 2004-11-04 | Becton, Dickinson And Company | Immuno-amplification |
WO2004104229A2 (en) * | 2003-05-16 | 2004-12-02 | Vickery Michael C L | Internal control nucleic acid molecule for nucleic acid amplification systems |
US7713923B2 (en) * | 2003-06-25 | 2010-05-11 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
EP1636250B1 (en) * | 2003-06-25 | 2016-01-06 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and uses thereof |
WO2005037071A2 (en) * | 2003-10-14 | 2005-04-28 | Monogram Biosciences, Inc. | Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
US7785843B2 (en) * | 2004-06-23 | 2010-08-31 | Sequenom, Inc. | Target-specific compomers and methods of use |
US20060110724A1 (en) | 2004-11-19 | 2006-05-25 | Burkhardt William Iii | Quantitative real-time assay for noroviruses and enteroviruses with built in quality control standard |
US20060204999A1 (en) * | 2005-03-14 | 2006-09-14 | Stephen Macevicz | Detecting molecular complexes |
EP2283851B1 (en) | 2005-04-25 | 2023-06-07 | Massachusetts Institute of Technology | Compositions for promoting hemostasis |
WO2007059312A2 (en) | 2005-11-16 | 2007-05-24 | Ambrx, Inc. | Methods and compositions comprising non-natural amino acids |
EP2012842B1 (en) * | 2006-04-25 | 2018-04-04 | Massachusetts Institute of Technology | Compositions and methods for affecting movement of contaminants, bodily fluids or other entities and/or affecting other physiological conditions |
EP2066697A2 (en) * | 2006-09-26 | 2009-06-10 | Massachusetts Institute of Technology | Modified self-assembling peptides |
CN104645329A (en) | 2007-11-30 | 2015-05-27 | Abbvie公司 | Protein formulations and methods of making same |
US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
KR20110036638A (en) | 2008-07-25 | 2011-04-07 | 리차드 더블유. 와그너 | Protein screening methods |
WO2011072482A1 (en) | 2009-12-14 | 2011-06-23 | The University Of Hong Kong | Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
ES2926988T3 (en) | 2011-03-15 | 2022-10-31 | X Body Inc | Antibody screening methods |
EP3421592B1 (en) | 2011-04-28 | 2023-09-13 | The Board of Trustees of the Leland Stanford Junior University | Identification of polynucleotides associated with a sample |
EP2788379B1 (en) | 2011-12-05 | 2020-02-05 | X-Body, Inc. | Pdgf receptor beta binding polypeptides |
SG11201510312RA (en) | 2013-06-28 | 2016-01-28 | X Body Inc | Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes |
US10519436B2 (en) | 2013-09-23 | 2019-12-31 | X-Body, Inc. | Methods and compositions for generation of binding agents against cell surface antigens |
AU2015271324B2 (en) * | 2014-06-06 | 2019-09-12 | Herlev Hospital | Determining antigen recognition through barcoding of MHC multimers |
EP3155426B1 (en) | 2014-06-13 | 2023-07-19 | Immudex ApS | General detection and isolation of specific cells by binding of labeled molecules |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998031700A1 (en) * | 1997-01-21 | 1998-07-23 | The General Hospital Corporation | Selection of proteins using rna-protein fusions |
WO1999051773A1 (en) * | 1998-04-03 | 1999-10-14 | Phylos, Inc. | Addressable protein arrays |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4587044A (en) | 1983-09-01 | 1986-05-06 | The Johns Hopkins University | Linkage of proteins to nucleic acids |
DE3590766C2 (en) | 1985-03-30 | 1991-01-10 | Marc Genf/Geneve Ch Ballivet | |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
EP0494955B1 (en) | 1989-10-05 | 1998-07-15 | Optein, Inc. | Cell-free synthesis and isolation of novel genes and polypeptides |
US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
US5723286A (en) | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
WO1992002536A1 (en) | 1990-08-02 | 1992-02-20 | The Regents Of The University Of Colorado | Systematic polypeptide evolution by reverse translation |
US5264563A (en) | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
US5795747A (en) | 1991-04-16 | 1998-08-18 | Evotec Biosystems Gmbh | Process for manufacturing new biopolymers |
DE4112440C1 (en) | 1991-04-16 | 1992-10-22 | Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De | |
AU2313392A (en) | 1991-08-01 | 1993-03-02 | University Research Corporation | Systematic polypeptide evolution by reverse translation |
US5639603A (en) | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
US5270170A (en) | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
US5541061A (en) | 1992-04-29 | 1996-07-30 | Affymax Technologies N.V. | Methods for screening factorial chemical libraries |
US5565324A (en) | 1992-10-01 | 1996-10-15 | The Trustees Of Columbia University In The City Of New York | Complex combinatorial chemical libraries encoded with tags |
US6087186A (en) | 1993-07-16 | 2000-07-11 | Irori | Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
US5635602A (en) | 1993-08-13 | 1997-06-03 | The Regents Of The University Of California | Design and synthesis of bispecific DNA-antibody conjugates |
WO1995011922A1 (en) | 1993-10-29 | 1995-05-04 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
US5561043A (en) | 1994-01-31 | 1996-10-01 | Trustees Of Boston University | Self-assembling multimeric nucleic acid constructs |
DE69531148T2 (en) | 1994-01-31 | 2004-04-29 | Trustees Of Boston University, Boston | LIBRARIES MADE OF POLYCLONAL ANTIBODIES |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
EP0763202A4 (en) | 1994-05-23 | 1998-12-09 | Smithkline Beecham Corp | Encoded combinatorial libraries |
US5627024A (en) | 1994-08-05 | 1997-05-06 | The Scripps Research Institute | Lambdoid bacteriophage vectors for expression and display of foreign proteins |
US5559000A (en) | 1995-01-18 | 1996-09-24 | The Scripps Research Institute | Encoded reaction cassette |
US5751629A (en) | 1995-04-25 | 1998-05-12 | Irori | Remotely programmable matrices with memories |
DE19646372C1 (en) | 1995-11-11 | 1997-06-19 | Evotec Biosystems Gmbh | Conjugates of polypeptide and encoding nucleic acid |
JP3683282B2 (en) | 1996-10-17 | 2005-08-17 | 三菱化学株式会社 | Genotype-phenotype mapping molecule and use thereof |
US6261804B1 (en) * | 1997-01-21 | 2001-07-17 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
GB9703369D0 (en) * | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
GB9712512D0 (en) | 1997-06-16 | 1997-08-20 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
US5985575A (en) | 1998-05-20 | 1999-11-16 | Wisconsin Alumni Research Foundation | Tethered function assay for protein function |
PT1105360E (en) | 1998-08-17 | 2009-09-30 | Bristol Myers Squibb Co | Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
KR20010099821A (en) * | 1998-12-02 | 2001-11-09 | 추후기재 | Dna-protein fusions and uses thereof |
ATE439592T1 (en) | 1998-12-10 | 2009-08-15 | Bristol Myers Squibb Co | PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS |
-
2001
- 2001-01-04 AT AT01942678T patent/ATE322558T1/en not_active IP Right Cessation
- 2001-01-04 US US09/755,663 patent/US6489116B2/en not_active Expired - Lifetime
- 2001-01-04 DE DE60118527T patent/DE60118527D1/en not_active Expired - Lifetime
- 2001-01-04 JP JP2001553398A patent/JP2003520050A/en active Pending
- 2001-01-04 CA CA002396810A patent/CA2396810A1/en not_active Abandoned
- 2001-01-04 AU AU29279/01A patent/AU783689B2/en not_active Ceased
- 2001-01-04 EP EP01942678A patent/EP1250463B1/en not_active Expired - Lifetime
- 2001-01-04 WO PCT/US2001/000291 patent/WO2001053539A1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998031700A1 (en) * | 1997-01-21 | 1998-07-23 | The General Hospital Corporation | Selection of proteins using rna-protein fusions |
WO1999051773A1 (en) * | 1998-04-03 | 1999-10-14 | Phylos, Inc. | Addressable protein arrays |
Non-Patent Citations (1)
Title |
---|
ROBERTS ET AL.: "RNA-peptide fusions for the in vitro selection of peptides and proteins", PROC. NATL. ACAD. SCI. USA, vol. 94, November 1997 (1997-11-01), pages 12297 - 12302, XP002940042 * |
Cited By (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1377828A2 (en) * | 2001-04-10 | 2004-01-07 | Children's Medical Center Corporation | Methods of analysis and labeling of protein-protein interactions |
EP1377828A4 (en) * | 2001-04-10 | 2006-11-15 | Childrens Medical Center | Methods of analysis and labeling of protein-protein interactions |
US7846746B2 (en) | 2001-04-10 | 2010-12-07 | Children's Medical Center Corporation | Methods of analysis and labeling of protein-protein interactions |
US8932992B2 (en) | 2001-06-20 | 2015-01-13 | Nuevolution A/S | Templated molecules and methods for using such molecules |
US10669538B2 (en) | 2001-06-20 | 2020-06-02 | Nuevolution A/S | Templated molecules and methods for using such molecules |
EP1419274A1 (en) * | 2001-07-31 | 2004-05-19 | Phylos, Inc. | Modular assembly of nucleic acid-protein fusion multimers |
EP1419274A4 (en) * | 2001-07-31 | 2006-02-08 | Phylos Inc | Modular assembly of nucleic acid-protein fusion multimers |
DE10145226A1 (en) * | 2001-09-13 | 2003-04-10 | Lifebits Ag | Manufacture of carrier-bound molecules |
US10731151B2 (en) | 2002-03-15 | 2020-08-04 | Nuevolution A/S | Method for synthesising templated molecules |
US10730906B2 (en) | 2002-08-01 | 2020-08-04 | Nuevolutions A/S | Multi-step synthesis of templated molecules |
US11001835B2 (en) | 2002-10-30 | 2021-05-11 | Nuevolution A/S | Method for the synthesis of a bifunctional complex |
US9284600B2 (en) | 2002-10-30 | 2016-03-15 | Neuvolution A/S | Method for the synthesis of a bifunctional complex |
US10077440B2 (en) | 2002-10-30 | 2018-09-18 | Nuevolution A/S | Method for the synthesis of a bifunctional complex |
US9109248B2 (en) | 2002-10-30 | 2015-08-18 | Nuevolution A/S | Method for the synthesis of a bifunctional complex |
US9121110B2 (en) | 2002-12-19 | 2015-09-01 | Nuevolution A/S | Quasirandom structure and function guided synthesis methods |
US9096951B2 (en) | 2003-02-21 | 2015-08-04 | Nuevolution A/S | Method for producing second-generation library |
US11965209B2 (en) | 2003-09-18 | 2024-04-23 | Nuevolution A/S | Method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
US11118215B2 (en) | 2003-09-18 | 2021-09-14 | Nuevolution A/S | Method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
WO2005026387A1 (en) * | 2003-09-18 | 2005-03-24 | Nuevolution A/S | A method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
US11702652B2 (en) | 2005-12-01 | 2023-07-18 | Nuevolution A/S | Enzymatic encoding methods for efficient synthesis of large libraries |
US9574189B2 (en) | 2005-12-01 | 2017-02-21 | Nuevolution A/S | Enzymatic encoding methods for efficient synthesis of large libraries |
US11225655B2 (en) | 2010-04-16 | 2022-01-18 | Nuevolution A/S | Bi-functional complexes and methods for making and using such complexes |
US10941396B2 (en) | 2012-02-27 | 2021-03-09 | Becton, Dickinson And Company | Compositions and kits for molecular counting |
US11634708B2 (en) | 2012-02-27 | 2023-04-25 | Becton, Dickinson And Company | Compositions and kits for molecular counting |
US11702706B2 (en) | 2013-08-28 | 2023-07-18 | Becton, Dickinson And Company | Massively parallel single cell analysis |
US11618929B2 (en) | 2013-08-28 | 2023-04-04 | Becton, Dickinson And Company | Massively parallel single cell analysis |
US10927419B2 (en) | 2013-08-28 | 2021-02-23 | Becton, Dickinson And Company | Massively parallel single cell analysis |
US10954570B2 (en) | 2013-08-28 | 2021-03-23 | Becton, Dickinson And Company | Massively parallel single cell analysis |
USRE48913E1 (en) | 2015-02-27 | 2022-02-01 | Becton, Dickinson And Company | Spatially addressable molecular barcoding |
US11535882B2 (en) | 2015-03-30 | 2022-12-27 | Becton, Dickinson And Company | Methods and compositions for combinatorial barcoding |
US11390914B2 (en) | 2015-04-23 | 2022-07-19 | Becton, Dickinson And Company | Methods and compositions for whole transcriptome amplification |
US11332776B2 (en) | 2015-09-11 | 2022-05-17 | Becton, Dickinson And Company | Methods and compositions for library normalization |
US11845986B2 (en) | 2016-05-25 | 2023-12-19 | Becton, Dickinson And Company | Normalization of nucleic acid libraries |
US10640763B2 (en) | 2016-05-31 | 2020-05-05 | Cellular Research, Inc. | Molecular indexing of internal sequences |
US11220685B2 (en) | 2016-05-31 | 2022-01-11 | Becton, Dickinson And Company | Molecular indexing of internal sequences |
US11525157B2 (en) | 2016-05-31 | 2022-12-13 | Becton, Dickinson And Company | Error correction in amplification of samples |
US11467157B2 (en) | 2016-09-26 | 2022-10-11 | Becton, Dickinson And Company | Measurement of protein expression using reagents with barcoded oligonucleotide sequences |
US11782059B2 (en) | 2016-09-26 | 2023-10-10 | Becton, Dickinson And Company | Measurement of protein expression using reagents with barcoded oligonucleotide sequences |
US11460468B2 (en) | 2016-09-26 | 2022-10-04 | Becton, Dickinson And Company | Measurement of protein expression using reagents with barcoded oligonucleotide sequences |
US11319583B2 (en) | 2017-02-01 | 2022-05-03 | Becton, Dickinson And Company | Selective amplification using blocking oligonucleotides |
US10676779B2 (en) | 2017-06-05 | 2020-06-09 | Becton, Dickinson And Company | Sample indexing for single cells |
US10669570B2 (en) | 2017-06-05 | 2020-06-02 | Becton, Dickinson And Company | Sample indexing for single cells |
US11365409B2 (en) | 2018-05-03 | 2022-06-21 | Becton, Dickinson And Company | Molecular barcoding on opposite transcript ends |
US11773441B2 (en) | 2018-05-03 | 2023-10-03 | Becton, Dickinson And Company | High throughput multiomics sample analysis |
US11639517B2 (en) | 2018-10-01 | 2023-05-02 | Becton, Dickinson And Company | Determining 5′ transcript sequences |
US11932849B2 (en) | 2018-11-08 | 2024-03-19 | Becton, Dickinson And Company | Whole transcriptome analysis of single cells using random priming |
US11492660B2 (en) | 2018-12-13 | 2022-11-08 | Becton, Dickinson And Company | Selective extension in single cell whole transcriptome analysis |
US11661631B2 (en) | 2019-01-23 | 2023-05-30 | Becton, Dickinson And Company | Oligonucleotides associated with antibodies |
US11939622B2 (en) | 2019-07-22 | 2024-03-26 | Becton, Dickinson And Company | Single cell chromatin immunoprecipitation sequencing assay |
US11773436B2 (en) | 2019-11-08 | 2023-10-03 | Becton, Dickinson And Company | Using random priming to obtain full-length V(D)J information for immune repertoire sequencing |
US11649497B2 (en) | 2020-01-13 | 2023-05-16 | Becton, Dickinson And Company | Methods and compositions for quantitation of proteins and RNA |
US11661625B2 (en) | 2020-05-14 | 2023-05-30 | Becton, Dickinson And Company | Primers for immune repertoire profiling |
US11932901B2 (en) | 2020-07-13 | 2024-03-19 | Becton, Dickinson And Company | Target enrichment using nucleic acid probes for scRNAseq |
US11739443B2 (en) | 2020-11-20 | 2023-08-29 | Becton, Dickinson And Company | Profiling of highly expressed and lowly expressed proteins |
Also Published As
Publication number | Publication date |
---|---|
AU2927901A (en) | 2001-07-31 |
US6489116B2 (en) | 2002-12-03 |
ATE322558T1 (en) | 2006-04-15 |
CA2396810A1 (en) | 2001-07-26 |
EP1250463B1 (en) | 2006-04-05 |
EP1250463A1 (en) | 2002-10-23 |
US20010024784A1 (en) | 2001-09-27 |
AU783689B2 (en) | 2005-11-24 |
JP2003520050A (en) | 2003-07-02 |
EP1250463A4 (en) | 2004-03-24 |
DE60118527D1 (en) | 2006-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1250463B1 (en) | Sensitive, multiplexed diagnostic assays for protein analysis | |
US7022479B2 (en) | Sensitive, multiplexed diagnostic assays for protein analysis | |
AU634969B2 (en) | Method and reagents for detecting nucleic acid sequences | |
EP0779934B1 (en) | Compositions and methods for use in detection of analytes | |
EP2044219B1 (en) | Detectable nucleic acid tag | |
US20150141297A1 (en) | Methods and Compositions for Phototransfer | |
CA2400384A1 (en) | Methods and kits for proximity probing | |
US5702893A (en) | Hydrophobic nucleic acid probe | |
JP2001517068A (en) | Nucleic acid capture component | |
EP1041160A1 (en) | Methods for detecting mutation in base sequence | |
Vary | Triple-helical capture assay for quantification of polymerase chain reaction products | |
US20030082571A1 (en) | Linear nucleic acid and sequence therefor | |
JP2002017399A (en) | Method of detecting base polymorphism | |
US20050239078A1 (en) | Sequence tag microarray and method for detection of multiple proteins through DNA methods | |
WO1989009281A1 (en) | Method for amplifying and detecting nucleic acid in a test liquid | |
JP2001269197A (en) | Immobilized oligonucleotide probe | |
US20220025430A1 (en) | Sequence based imaging | |
JPH02215399A (en) | Detection of nucleic acid | |
KR20070083924A (en) | Nucleic acid fragments for detecting nucleic acid and method of detecting nucleic acid | |
JP3103806B1 (en) | Nucleic acid detection method | |
US20040121331A1 (en) | Methods of amplifying signals in multiplexed protein analysis | |
WO2024084249A1 (en) | Clonal amplification | |
JP2002209584A (en) | Method for detecting nucleotide polymorphism | |
JP2002125700A (en) | Method for analyzing double-stranded dna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 29279/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001942678 Country of ref document: EP Ref document number: 2396810 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2001 553398 Country of ref document: JP Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2001942678 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 29279/01 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001942678 Country of ref document: EP |